Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     

  • Bitcoin GBP

    51,095.78
    -671.09 (-1.30%)
     

  • CMC Crypto 200

    1,332.15
    -64.39 (-4.61%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Global Breast Biopsy Markets Report 2022: Market to Reach $1.75 Bn in 2026 - Rising Momentum of Liquid Biopsy

Research and Markets
·4-min read
Company Logo
Company Logo

Global Breast Biopsy Market

Global Breast Biopsy Market
Global Breast Biopsy Market

Dublin, June 06, 2022 (GLOBE NEWSWIRE) -- The "Global Breast Biopsy Market (Core Needle, Vacuum Assisted & Fine Needle Aspiration): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering.

The global breast biopsy market is forecasted to reach US$1.75 billion in 2026, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202.

Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However, the market growth is expected to be restrained by increasing possibility of infection associated with breast biopsy procedure.

ADVERTISEMENT

The global breast biopsy market by type can be segmented into the following segments: core needle biopsy (CNB), vacuum assisted biopsy (VAB) and fine needle aspiration biopsy (FNAB). In 2021, the dominant share of global breast biopsy market was held by core needle biopsy (CNB), followed by vacuum assisted biopsy (VAB).

The global breast biopsy market by image guided technology can be segmented as follows: mammography guided stereotactic biopsy, ultrasound guided biopsy, MRI guided biopsy and CT guided biopsy. The largest share of the market was held by mammography guided stereotactic biopsy, followed by ultrasound guided biopsy and MRI guided biopsy.

The company profiles of leading players (Hologic, Danaher Corporation, Becton, Dickinson & Company, Roche Group, Medtronic and Qiagen) are also presented in detail.

Key Topics Covered:

1. Overview
1.1 Breast Biopsy
1.1.1 Breast Biopsy - Introduction
1.1.2 Preparation of a Breast Biopsy
1.1.3 Results of a Breast Biopsy
1.1.4 Risks Associated with Breast Biopsy
1.2 Types of Breast Biopsies
1.2.1 Fine Needle Aspiration
1.2.2 Core Needle Biopsy
1.2.3 Vacuum Assisted Breast Biopsy
1.2.4 Direct & Frontal Biopsy
1.2.5 Excisional (Surgical) Biopsy

2. Impact of COVID-19
2.1 Impact of COVID-19 on Breast Biopsy Market
2.2 Impact of COVID-19 on Breast Biopsy Patient Population

3. Market Analysis
3.1 Global Breast Biopsy Market by Value
3.2 Global Breast Biopsy Market Forecast by Value
3.3 Global Breast Biopsy Market by Type
3.3.1 Global Core Needle Biopsy (CNB) Market by Value
3.3.2 Global Core Needle Biopsy (CNB) Market Forecast by Value
3.3.3 Global Vacuum Assisted Biopsy (VAB) Market by Value
3.3.4 Global Vacuum Assisted Biopsy (VAB) Market Forecast by Value
3.3.5 Global Fine Needle Aspiration Biopsy (FNAB) Market by Value
3.3.6 Global Fine Needle Aspiration Biopsy (FNAB) Market Forecast by Value
3.4 Global Breast Biopsy Market by Image Guided Technology
3.4.1 Global Mammography Guided Stereotactic Breast Biopsy Market by Value
3.4.2 Global Mammography Guided Stereotactic Breast Biopsy Market Forecast by Value
3.4.3 Global Ultrasound Guided Breast Biopsy Market by Value
3.4.4 Global Ultrasound Guided Breast Biopsy Market Forecast by Value
3.4.5 Global MRI Guided Breast Biopsy Market by Value
3.4.6 Global MRI Guided Breast Biopsy Market Forecast by Value
3.4.7 Global CT Guided Breast Biopsy Market by Value
3.4.8 Global CT Guided Breast Biopsy Market Forecast by Value
3.5 Global Breast Biopsy Market by Region

4. Regional Market
4.1 North America
4.1.1 North America Breast Biopsy Market by Value
4.1.2 North America Breast Biopsy Market Forecast by Value
4.2 Europe
4.2.1 Europe Breast Biopsy Market by Value
4.2.2 Europe Breast Biopsy Market Forecast by Value
4.2.3 Europe Breast Biopsy Market by Type
4.2.4 Europe Breast Biopsy Market Value Forecast by Type
4.3 Asia Pacific
4.3.1 Asia Pacific Breast Biopsy Market by Value
4.3.2 Asia Pacific Breast Biopsy Market Forecast by Value
4.3.3 Asia Pacific Breast Biopsy Market by Type
4.3.4 Asia Pacific Breast Biopsy Market Value Forecast by Type
4.4 ROW
4.4.1 ROW Breast Biopsy Market by Value
4.4.2 ROW Breast Biopsy Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Prevalence of Breast Cancer
5.1.2 Increase in Aged Female Population
5.1.3 Incorporation of Minimally Invasive Breast Biopsies
5.1.4 Rise in Initiatives Regarding Awareness of Breast Cancer
5.2 Key Trends & Developments
5.2.1 Rising Momentum of Liquid Biopsy
5.3 Challenges
5.3.1 Risk of Infections
5.3.2 Lack of Healthcare Infrastructure in Developing Countries

6. Company Profiles

  • Becton, Dickinson & Company

  • Danaher Corporation

  • Hologic

  • Medtronic

  • Qiagen

  • Roche Group

For more information about this report visit https://www.researchandmarkets.com/r/51y747

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900